the Baker Lab
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Expedition to Antarctica advances research on potential melanoma treatment
Expedition to Antarctica advances research on potential melanoma treatment Lisa Lock Scientific Editor Andrew Zinin Lead Editor Deep beneath the icy waters surrounding Antarctica, a small marine organism may hold clues to a future cancer treatment. Researchers from USF recently returned from a six-week expedition in one of the most remote environments on Earth to study a species of ascidian, or sea squirt, that contains a bacterium capable of killing melanoma cancer cells. The discovery was...
Lab evolution recreates COVID's path to omicron in months, reveals key conditions
Lab evolution recreates COVID's path to omicron in months, reveals key conditions Sadie Harley Scientific Editor Robert Egan Associate Editor A key step in the origin of many pandemics occurs when an animal-borne virus infects humans and then evolves to spread more efficiently from person to person. That is why scientists and physicians keep a close watch on viruses that could jump from animals to humans, such as emerging strains of avian flu and bat coronaviruses, as well as viruses that...
When AI Builds Itself: Our progress toward recursive self-improvement
For most of AI’s history, humans drove every step in its development cycle. But at Anthropic, we are delegating a growing share of AI development to AI systems themselves, which is speeding up our work. Taken far enough, and given enough compute, that trend points to an AI system capable of fully autonomously designing and developing its own successor.
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said Phelan who enlisted in the U.S. Army Reserve in 1999 and was deployed to Iraq in 2003.